There are treatments for myasthenia gravis, but there are no specific drugs to cure myasthenia gravis. Treatment is aimed at improving the clinical symptoms of myasthenia gravis, controlling complications, and reducing recurrence rates. Myasthenia gravis (MG) is an acquired autoimmune disease mediated by autoantibodies, which is clinically characterized by fluctuating weakness and easy fatigability of skeletal muscles in varying degrees, with morning and evening weakness, most often involving extraocular muscles. According to the latest research progress and guidelines, its treatments include intravenous immunoglobulin (gammaglobulin), targeted biologics (rituximab, eculizumab), methotrexate, thymectomy, plasma exchange, and autologous hematopoietic stem cell transplantation. With the development of Chinese medicine, traditional Chinese medicine, acupuncture, tuina and other traditional Chinese therapies have also become an important tool. Prompt medical attention should be sought if any relevant symptoms appear.